Dark

SRPT
Sarepta Therapeutics,, Inc. Common Stock
stock NASDAQ

At Close

Mar 13, 2026 3:59:59 PM EDT

16.41USD-3.697%(-0.63)2,288,062

15.60Bid 17.52Ask 1.92Spread

Pre-market

Mar 13, 2026 9:28:30 AM EDT

17.34USD+1.761%(+0.30)9,796

After-hours

Mar 13, 2026 4:54:30 PM EDT

16.40USD-0.061%(-0.01)52,345

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

1.72B

CEO

Douglas Ingram

Headquarters

Cambridge, Massachusetts, USA

Industry

Biotechnology

Last Split

Jul 12, 20121for5.9999reverse

BCRX NVAX GILD ALNY NLNK PTCT RTRX IONS HEB XLV

SRPT Stats

Avg. Vol. 10 Day

2,579,882

Avg. Vol. 30 Day

2,451,553

Employees

255

Market Cap

1,721,832,261

Shares Out.

104,989,772

On/Off Exchange

58%/42%

6 Month Beta

2.97

1 Year Beta

1.65

2 Year Beta

1.27

3 Year Beta

1.13

52 Week Low

10.42

52 Week High

103.32

SMA50

19.61

SMA200

20.79

1 Week

-1.86%

1 Month

-7.81%

3 Month

-23.83%

6 Month

-5.69%

1 Year

-83.33%

2 Year

-86.55%

5 Year

-81.03%

Profile

sarepta therapeutics is a biopharmaceutical company focused on the discovery and development of unique rna-targeted therapeutics for the treatment of rare, infectious and other diseases. the company is primarily focused on rapidly advancing the development of its potentially disease-modifying dmd drug candidates, including its lead dmd product candidate, eteplirsen, designed to skip exon 51. sarepta is also developing therapeutics for the treatment of infectious diseases, such as drug-resistant bacteria and other rare human diseases. for more information, please visit us at www.sarepta.com.

SRPT Stock Summary

Sarepta Therapeutics,, Inc. Common Stock (NASDAQ:SRPT) stock price today is $16.41, and today's volume is 2,288,062. SRPT is down -3.697% today. The 30 day average volume is 2,451,553. SRPT market cap is 1.72B with 104,989,772 shares outstanding.